COVENANT MEDICAL CENTER
1. Target Overview & Investment Thesis
COVENANT MEDICAL CENTER is a 360-bed suburban community hospital in LUBBOCK, TX with $437.7M in net patient revenue and a -23.9% operating margin. The hospital serves a payer mix of 31.4% Medicare, 0.4% Medicaid, and 68.2% commercial.
Thesis: Undervalued. Our ML models identify $32.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -23.9% to -16.6% (+736bps).
| Net Revenue HCRIS | $437.7M |
| Current EBITDA COMPUTED | $-104.7M |
| Operating Margin COMPUTED | -23.9% |
| Occupancy HCRIS | 64.7% |
| Revenue / Bed COMPUTED | $1.2M |
| Net-to-Gross HCRIS | 11.1% |
| Distress Probability ML | 42.8% |
2. Market Context & Competitive Position
TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -23.9% places it below the state median. Among 108 size-comparable peers (180-720 beds), the median margin is 4.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (180-720), prioritizing same-state peers. 108 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| COVENANT MEDICAL CENTER (Target) | TX | 360 | $437.7M | -23.9% |
| SCOTT AND WHITE MEMORIAL HOSPI | TX | 616 | $1.85B | -10.5% |
| CHILDRENS MEDICAL CENTER OF DA | TX | 377 | $1.56B | 10.3% |
| COOK CHILDRENS MEDICAL CENTER | TX | 423 | $1.51B | 16.5% |
| CHI ST LUKES HEALTH BAYLOR MED | TX | 628 | $1.10B | -9.5% |
| UNIVERSITY HEALTH SYSTEM | TX | 657 | $1.10B | -50.0% |
| TX HLTH HARRIS METHODIST HOSPI | TX | 653 | $1.03B | 4.1% |
| CHRISTUS MOTHER FRANCES HOSP-T | TX | 518 | $971.6M | -17.0% |
| MEDICAL CITY PLANO | TX | 573 | $936.8M | 40.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $32.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $9.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $8.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $8.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $5.3M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $280K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-104.7M |
| + RCM Uplift | +$32.2M |
| Pro Forma EBITDA | $-72.5M |
| Current Margin | -23.9% |
| Pro Forma Margin | -16.6% |
| WC Released (1x) | $16.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-161.0M | $-368.3M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-161.0M | $-457.5M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-144.9M | $-403.5M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-144.9M | $-482.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-177.2M | $-477.1M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-177.2M | $-582.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 108 hospitals with 180-720 beds
- Same-state prioritization (n=109)
- Comp margins: P25=-8.0% / P50=4.6% / P75=14.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.